Financial Analysis: Elevation Oncology Inc (ELEV)’s Ratios Unveil Key Insights

Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.

As of close of business last night, Elevation Oncology Inc’s stock clocked out at $0.33, up 5.49% from its previous closing price of $0.31. In other words, the price has increased by $5.49 from its previous closing price. On the day, 3.46 million shares were traded. ELEV stock price reached its highest trading level at $0.3411 during the session, while it also had its lowest trading level at $0.3025.

Ratios:

To gain a deeper understanding of ELEV’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 21.21 and its Current Ratio is at 21.21. In the meantime, Its Debt-to-Equity ratio is 0.52 whereas as Long-Term Debt/Eq ratio is at 0.52.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Stephens on March 24, 2025, Downgraded its rating to Equal-Weight and sets its target price to $1 from $5 previously.

On March 21, 2025, Piper Sandler Downgraded its rating to Neutral which previously was Overweight but kept the price unchanged to $0.70.

Leerink Partners Downgraded its Outperform to Market Perform on March 21, 2025, while the target price for the stock was maintained at $1.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ELEV now has a Market Capitalization of 19582666 and an Enterprise Value of -42467336.

Stock Price History:

The Beta on a monthly basis for ELEV is 1.56, which has changed by -0.9174564 over the last 52 weeks, in comparison to a change of 0.05279863 over the same period for the S&P500. Over the past 52 weeks, ELEV has reached a high of $4.53, while it has fallen to a 52-week low of $0.22. The 50-Day Moving Average of the stock is -26.12%, while the 200-Day Moving Average is calculated to be -61.14%.

Shares Statistics:

It appears that ELEV traded 1.60M shares on average per day over the past three months and 1136440 shares per day over the past ten days. A total of 59.13M shares are outstanding, with a floating share count of 52.07M. Insiders hold about 12.09% of the company’s shares, while institutions hold 65.79% stake in the company. Shares short for ELEV as of 1743379200 were 8159101 with a Short Ratio of 5.11, compared to 1740700800 on 8556195. Therefore, it implies a Short% of Shares Outstanding of 8159101 and a Short% of Float of 14.549999999999999.

Dividends & Splits

Against a Trailing Annual Dividend Yield of 0.0

Most Popular